AMBUJACEM Charts, Analysis and Tips

home > cement > ambujacem

Technical Analysis

Technical Strength: 3.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 43.6. According to RSI analysis, ambujacem is weak. 3.0 AMBUJACEM RSI Chart
MACD (?) MACD: 0.499 and Signal Line: 0.896. According to MACD analysis, ambujacem is marginally weak. 3.0 AMBUJACEM MACD Chart
Simple Moving Average (?) Price just got below it's 50-day simple moving average which is a negative signal. According to simple moving average analysis, ambujacem is in a downtrend. Resistance level is at 230. 1.0 AMBUJACEM Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 200-day exponential moving average which is a negative signal. Price just got below it's 50-day exponential moving average which is a negative signal. According to exponential moving average analysis, ambujacem is in a downtrend. Resistance level is at 229. 0.0 AMBUJACEM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.307. 5.0 AMBUJACEM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 226.6022 and 220.95. Resistance level is 244.9. 6.5 AMBUJACEM Fibonacci Retracement Chart
Average True Range (?) ATR: 4.54 NA AMBUJACEM Average True Range Chart
Average Directional Index (?) ADX is 19 which means AMBUJACEM is in a trading range and there is no trend. NA AMBUJACEM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 27, 2017
Open Price 229.8
High Price 230.0
Low Price 226.95
Close Price 227.6
Absolute Change -2.3
Percentage Change -1%
Weekly Change -2.82%
Monthly Change -1.9%
Yearly Change 4.33%
52-week high 281.7
52-week low 191.0
Corporate Actions
ExDate Purpose
March 16, 2017 DIV - RS 1.20 PER SHARE
August 02, 2016 INT DIV-RS 1.60 PER SHARE
August 02, 2016 INTERIM DIVIDEND
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.979
Confidence in Beta15.7%
Market Capital Rs. 35274.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 27 March 2017: Deliverable Quantity:9.89e+05 NA AMBUJACEM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 27 March 2017: Daily Volatility:0.2216 NA AMBUJACEM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 27 March 2017: PCR_OI:0.372 PCR:0.454 NA AMBUJACEM PCR Chart
Premium (?) 27 March 2017 Premium: 0.95 Futures OI:9695000.0 NA AMBUJACEM Premium Chart
Option_MAX_OI (?) 27 March 2017: Price:227.6 Put with maximum OI:225.0 Call with maximum OI:240.0 NA AMBUJACEM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 30, 2017 228.55 9695000.0 1817.0 2174.0 227.6
April 27, 2017 229.15 3160000.0 1037.0 1376.0 227.6

Announcements

March 27, 2017 ATrading WindowAmbuja Cements Limited has informed the Exchange that the Trading Window for dealing in the securities of the Company will remain closed from April 01, 2017 till 48 hours after the declaration of the Quarterly Financial Results by the Company to the Stock Exchanges.
March 22, 2017 AFinancial Results UpdatesAmbuja Cements Limited has informed the Exchange regarding Para 2.6.1 (ii) - Review of IND-AS compliant results of corresponding quarters of previous year (for Ambuja it is Mar 16, June 16 quarters and Sep 16 quarters).
See all Announcements

Board Meetings

Date Meeting Date Purpose
February 01, 2017 February 20, 2017 IResults/DividendInter alia, to consider and take on record the Audited Annual Financial Results for the Corporate Financial Year ended December 31, 2016 and to recommend final dividend on equity shares.
October 13, 2016 November 03, 2016 TResultsTo consider the Unaudited Financial Results for the Third Quarter ended September 30, 2016 of the Corporate Financial Year 2016.
See all Board Meetings

AMBUJACEM is part of...

Index Weightage
NIFTY NA
CNXMNC NA
CNXCMMDTY NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 223.3 Rs. 225.1 Rs. 226.4 Rs. 228.2 Rs. 229.4 Rs. 231.2 Rs. 232.5